- Avicanna (AVCN) has been chosen by Shoppers Drug Mart as its partner to transition its Medical Cannabis by Shoppers business
- Avicanna will introduce MyMedi.ca, a new medical cannabis care platform.
- MyMedi.ca will provide a collection of formulas of products in collaboration with Canadian licensed producers, and comprehensive training programs for the medical community
- Avicanna Inc. (AVCN) opened trading at C$0.38 per share
Avicanna (AVCN) has been chosen by Shoppers Drug Mart as its partner to transition its Medical Cannabis by Shoppers business.
Medical Cannabis by Shoppers provides patients access to medical cannabis products from more than 30 licensed cannabis brands. Avicanna will introduce MyMedi.ca, a new medical cannabis care platform.
MyMedi.ca will provide a collection of formulas of products in collaboration with Canadian licensed producers, and comprehensive training programs for the medical community.
Shoppers Drug Mart’s President, Jeff Leger stated that he and his team are confident they have found the right partner in Avicanna to continue to support them.
“As we move away from medical cannabis distribution, we remain firm in our belief that this medication should be dispensed in pharmacies like all others and will continue our advocacy to that end.”
It is anticipated that the transfer will take place over the next three months.
Avicanna is a commercial-stage international biopharmaceutical company. It focuses on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments.
Avicanna Inc. (AVCN) opened trading at C$0.38 per share.
